2012
DOI: 10.3892/etm.2012.493
|View full text |Cite
|
Sign up to set email alerts
|

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

Abstract: Abstract. Insulin-like growth factor-1 receptor (IGF-1R) and matrix metalloproteinase-7 (MMP-7) have been reported to be related to tumor invasion and metastasis in various malignancies. The aim of this study was to evaluate the expression levels of IGF-1R and MMP-7 in resected non-small cell lung cancer (NSCLC) and to examine the relationship of such levels to clinical characteristics and survival. Expression was measured immunohistochemically. The percentage of stained cells was multiplied by the staining in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
22
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 20 publications
2
22
0
1
Order By: Relevance
“…A phase II study showed that agents which target at IGF-1R exhibited a promising efficacy against advanced NSCLC [18], whereas, the prognostic value of IGF-1R is still controversial. Yamamoto et al [9] demonstrated that the overall survival (OS) in NSCLC patients with IGF-1R-high expression was significantly poorer than those in IGF-1R-low expression patients, however, Kim et al [19] revealed that the expression level of IGF-1R in NSCLC was not related to OS. To clarify the precise prognostic and clinical value of IGF-1R in NSCLC, a meta-analysis is needed.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A phase II study showed that agents which target at IGF-1R exhibited a promising efficacy against advanced NSCLC [18], whereas, the prognostic value of IGF-1R is still controversial. Yamamoto et al [9] demonstrated that the overall survival (OS) in NSCLC patients with IGF-1R-high expression was significantly poorer than those in IGF-1R-low expression patients, however, Kim et al [19] revealed that the expression level of IGF-1R in NSCLC was not related to OS. To clarify the precise prognostic and clinical value of IGF-1R in NSCLC, a meta-analysis is needed.…”
Section: Introductionmentioning
confidence: 99%
“…When IGF-1 and IGF-2 bind to the extracellular subunit domain of IGF-1R, the tyrosine kinase activity of IGF-1R can be activated and the activation of IGF-1R can trigger a cascade of reactions involving signal transduction pathways such as Ras, Raf and mitogen-activated protein kinase (MAPK) [8]. It is reported that the overexpression of IGF-1R can promote tumor growth, progression, invasion and metastasis [9]. A large number of studies have revealed that IGF-1R was dysregulated in a variety of cancers including breast cancer [10, 11], liver cancer [12, 13], gastric cancer [14] and lung cancer [15, 16], suggesting a vital role of IGF-1R in cancers.…”
Section: Introductionmentioning
confidence: 99%
“…MMP7 is over-expressed in pancreatic, gastric, and colorectal cancers [32,33], and MMP levels correlate with clinical stages of malignancy, including lymph node involvement and distant metastasis [34][35][36]. Our results showing the decreased expression of several genes involved in invasion and metastasis in A549 cells treated with MGX may facilitate elucidation of the anticancer mechanisms of MGX.…”
Section: Discussionmentioning
confidence: 96%
“…However, Yamamoto et al (2012) claimed that IGF1R overexpression was related to lymph node metastasis and tumor recurrence. Also, Sun et al (2012) claimed that IGF1R expression played a role in the development of resistance to cisplatin and radiotherapy in NSCLC.…”
Section: Discussionmentioning
confidence: 99%